Ortho Clinical Diagnostics Holdings plc Accounts Payable

Ortho Clinical Diagnostics Holdings plc (OCDX) currently reports a accounts payable of $170M as of April 2022. That compares with $130M in the prior-year period — up 30.1% year over year. Use the charts on this page to explore Ortho Clinical Diagnostics Holdings plc's accounts payable history and peer comparisons.

Ortho Clinical Diagnostics Holdings plc's accounts payable increased from $130M to $170M — a 30.1% year-over-year increase (period ending April 2022). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Ortho Clinical Diagnostics Holdings plc reported $170M in accounts payable as of April 2022. That compares with $130M in the prior-year period — up 30.1% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current accounts payable of $170M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Ortho Clinical Diagnostics Holdings plc, and consider following OCDX for alerts when major investors trade the stock.

Ortho Clinical Diagnostics Holdings plc is classified in the Healthcare sector. On accounts payable, it currently shows $170M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing OCDX with unrelated industries.